Radiation Biology of Low Doses
by R. E. J. Mitchel
Radiation Biology and Health Physics Branch, AECL, Chalk
River Laboratories,
Chalk River ON. Canada, K0J 1P0
November 29, 2001 |
|
All current
radiation risk estimates and all radiation-protection standards and practices are based on
the so-called Linear No-Threshold Hypothesis which states that risk is
linearly proportional to dose, without a threshold. This hypothesis therefore predicts
that:
every
dose, no matter how low, carries with it some risk
risk per
unit dose is constant, additive, and can only increase with dose
biological variables are insignificant compared to dose
This talk
summarizes results from some of our low dose and/or low dose rate experiments with low LET
radiation in human and rodent cells, and in animals, and determines if the results support
or reject the LNT hypothesis as it affects the risk of most concern, cancer. It is
important to recognize that cancer arises from changes in a single cell and, therefore,
this defines the limits of the meaning of low dose. Unlike the concept of
whole body dose, where dose is averaged over all cells in the body, a single cell is the
smallest volume that is relevant for carcinogenic risk. The lowest possible dose is,
therefore, that dose which can be deposited in a single cell.
It is also important to recognize some physical
characteristics of radiation:
radiation deposits energy, and damage, in tracks
the smallest dose a cell can receive is that
deposited by a single track
at total doses which are less than one track/cell, not all cells
are hit, i.e., some cells receive no dose; however, those that are hit still receive the
dose deposited by one track.
While the
lowest possible dose to a cell is that deposited by one track, the actual dose depends on
the nature of the radiation. For example, a single alpha particle track can deposit tens
of cGy while a single 60Co-g ray will
deposit, on average, about 1 mGy.
When DNA damage is created by radiation in a cell,
there are three possible outcomes, an error-free repair which restores the cell to normal,
cell death by apoptosis, or error prone repair that creates a mutation and cancer risk.
The LNT hypothesis predicts that risk is influenced only by dose, and therefore that the
relative proportions of these three biological possibilities must be constant. If they
were not constant, then risk would vary with their relative proportions, i.e., not only as
a function of dose.
We have
tested the influence of prior low doses and low dose rate exposures on the ability of
normal human skin cells to repair subsequent acute radiation damage to DNA, which results
in breaks in chromosomes. The combined exposure resulted in less broken chromosomes
(measured as reduced micronucleus frequency) than the single acute exposure alone. The low
dose rate exposure stimulated the cells to increase their ability to repair broken
chromosomes, such that the consequences of a second large exposure were reduced. The same
result occurred if the initial exposure was 500 mGy, or was 1 mGy, the lowest g dose possible in a single cell (Figure 1).
 |
Figure 1. Ability to repair broken chromosomes in cells adapted by
exposure to low doses |
This
adaptive response to low doses of radiation can be seen in many other situations. For
example, the influence of a low dose on cell death by apoptosis has also been tested.
Those results show that low doses amplify the probability of apoptotic cell death
resulting from a second exposure. This sensitization of cells to radiation-induced cell
death increases the probability that a cell will die rather than survive with a mutation,
another type of adaptive response that is believed to reduce cancer risk in the whole
organism. |
| As a measure of the overall effect
of these processes, we used an assay that measures the frequency at which rodent cells in
tissue culture are transformed into cancer cells. We showed that a low dose rate exposure
immediately before a large acute exposure did not further increase risk, as predicted by
the LNT hypothesis, but actually decreased cancer risk by 2-3 fold (Table 1). In the
absence of the second large exposure, an average of one track per cell (1 mGy) reduced the
risk of cancer formation below that which occurred spontaneously in the absence of any
radiation exposure. Higher doses, up to 100 mGy delivered at a low dose rate, produced the
same 2-3 fold reduction in spontaneous transformation risk (Table 2). Since at 1 mGy not
all cells actually receive a track of radiation, these results also indicate that some
cells are protected in response to signals received from other cells that did receive a
radiation track, an example of the bystander effect for adaption to radiation.
Table 1. Reduction in the risk of radiation-induced malignant
transformation by a prior chronic exposure
Treatment |
Transformation
Frequency
(x 10-4) |
|
|
Control |
3.7 |
4
Gy (high dose rate) |
41 |
100
mGy (low dose rate) + 4 Gy (high dose rate) |
16 |
Table 2.
The influence of low doses delivered at low dose rate (2.4 mGy/min) on the risk of
spontaneous malignant transformation.
Treatment |
Transformation
Frequency
(x 10-3) |
Control |
1.8 |
1.0
mGy |
0.62 |
10
mGy |
0.39 |
100
mGy |
0.49 |
|
|
The results show that low dose
radiation induces an increase in error-free DNA repair competence. That repair system
increases the probability of correctly repairing either radiation-induced or spontaneous
DNA damage, or of triggering cell death if the repair is incorrect. This response
therefore reduces the overall risk of either radiation-induced or spontaneous
transformation to malignancy. It is apparent from these experiments that biological
variables are important in determining the consequences of radiation exposures and that
the risk of DNA damage is neither constant, nor additive, nor increasing with dose. Low
doses or doses delivered at low dose rate reduce rather than increase risk in normal
cells. The results contradict the LNT hypothesis.
We have
reported the results of similar investigations in mice. In one experiment, low doses of in
vivo b-irradiation
of mouse skin 24 h prior to treatment with a DNA damaging chemical carcinogen reduced
pre-malignant tumor frequency by about 5-fold. This result is consistent with the
cell-based studies described above. It implies that the radiation exposure stimulated an
error-free DNA repair system that was able to recognize and remove much of the chemically
produced DNA damage. In another experiment, a prior low dose exposure delivered at low
dose rate delayed the onset of myeloid leukemia induced in genetically normal mice by a
subsequent exposure to a large dose (Table 3).
Table 3.
Extension of latency period in mice developing acute myeloid leukemia
Average
Average
Treatment
Lifespan (Days)
Life Lost (Day
Control 727
0
1.0
Gy
486
241
100 mGy, 24h, 1.0 Gy
578
149
The
protective responses observed in mammalian cells and in animals are consistent with those
seen in lower eukaryotes, including yeast, indicating that they are evolutionarily
conserved and lending credence to the idea that such responses are the normal and expected
consequences of low dose exposures.
It seems clear that in normal
cells and normal adult animals, low doses and low dose rate exposures to low LET radiation
decrease rather than increase cancer risk. However, for human radiation protection, the
effects of low doses in two other important situations, exposure of cancer prone
individuals and exposure of a fetus, are less clear and we are investigating those
problems. We have recently examined cancer risk after low dose, low dose rate exposure in
mice that are radiation sensitive and cancer prone due to a genetic defect (heterozygosity
for the gene Trp53). We showed that a single low dose (10 mGy) protected these mice
against spontaneous cancer formation by increasing tumor latency (Figure 2), the same
protective response seen in genetically normal mice (Table 3).
 |
Figure 2. Latency of spinal
osteosarcomas in Trp53 +/- mice |
The low dose restored about half
the life span lost solely as a result of the genetic defect in the absence of radiation, a
change similar to that seen in normal mice (Table 3).
Another study examining
malformations in irradiated fetal mice showed that low doses can also induce an adaptive
response that protects against radiation induced teratogenic effects (shortened tails,
Figure 3), although this can occur only at certain times of organ development, and defects
in the Trp53 gene can alter that protection (Figure 3).
 |
Figure 3. The influence of a prior low dose on reduced tail length
resulting from a high radiation exposure. Fetal mice were exposed to 30 cGy, 24h prior to
a 4 Gy exposure on gestational day 11. Tail lengths were measured on gestational
day 18. Circles, Trp53 normal; Triangles, Trp53 heterozygous; Closed symbols, 4 Gy; Shaded
symbols, 30 cGy + 4 Gy; Open symbols, controls. |
|
Conclusions
Since, at
low doses and dose rates of low LET radiation, there are no data in the literature that
support the LNT as a general hypothesis for cancer risk, and considerable evidence
contradicting it, including the evidence given above, then this hypothesis must be
rejected. Some of the basic principals used in radiation protection, such as ALARA, as
low as reasonably achievable, and the precautionary
principle are not consistent with the biology of low
doses. It is time for a new risk based approach to radiation protection, firmly linked to
the actual biological responses.
REFERENCES
1. R.
E. J. Mitchel and A. Trivedi, Radiation: What Determines the Risk? In: Biological Effects and Physics of Solar and Galactic Cosmic
Radiation, C.E. Seenbergy et al. (eds.), Plenum Press, New York, Part B, pp. 859-870
(1993).
2.
R. E. J. Mitchel, E.I. Azzam and S.M. de Toledo, Adaption to Ionizing Radiation
in Mammalian Cells. In: Stress-Inducible Processes in
Higher Eukaryotes, T. Koval (editor), Plenum Press, New York, pp. 221-243 (1997).
3.
E.J. Broome, D.L. Brown and R.E.J. Mitchel, Adaption of human fibroblasts to
radiation alters biases in DNA repair at the chromosome level. Int. J. Radiat. Biol. 75, 681-690 (1999).
4.
E.I. Azzam, G. P. Raaphorst and R. E. J. Mitchel, Radiation-Induced Adaptive
Response for Protection Against Micronucleus Formation and Neoplastic Transformation in
C3H 10t½ Mouse Embryo Cells, Radiation Research. 138,
S28-S31(1994).
5.
E.I. Azzam, S.M. de Toledo, G. P. Raaphorst and R. E. J. Mitchel, Low-Dose
Ionizing Radiation Decreases the Frequency of Neoplastic Transformation to a Level Below
the Spontaneous Rate in C3H 10t½ Cells, Radiation
Research. 146, 369-373 (1996).
6.
S. P. Cregan, D. L. Brown and R. E. J. Mitchel, Apoptosis and the Adaptive
Response in Human Lymphocytes. Int. J. Radiat. Biol.
75, 1087-1094 (1999).
7.
S. P. Cregan, B. P. Smith, D. L. Brown and R. E. J. Mitchel, Two Pathways for
the Induction of Apoptosis in Human Lymphocytes.
Int. J. Radiat. Biol. 75, 1069-1086
(1999).
8.
R. E. J. Mitchel, N. J. Gragtmans and D. P. Morrison, Beta-Radiation-Induced
Resistance to MNNG Initiation of Papilloma but not Carcinoma Formation in Mouse Skin. Radiat. Res. 121,
180-186 (1990).
9.
R. E. J. Mitchel, J.S. Jackson, R. A. McCann and D. R. Boreham, The Adaptive
Response Modifies Latency For Radiation-Induced Myeloid Leukemia In CBA/H Mice. Radiat. Res. 152,
273-279, (1999).
10. Y. Xu, C. L. Greenstock, A. Trivedi and R. E. J. Mitchel, Occupational
Levels of Radiation Exposure Induce Surface Expression of Interleukin-2 Receptor in
Stimulated Human Peripheral Blood Lymphocytes.
Radiation and Environmental Biophysics. 35, 89-93 (1996).
11. D. R. Boreham, A. Trivedi and R. E. J. Mitchel, Radiation
and Stress Response in Saccharomyces Cerevisiae, In:
Molecular Biology of Yeast in Relation to Biotechnology, R. Prasad (editor). Omega
Scientific, pp. 295-314 (1991).
12. J. Graham,. D.J. Higson, J-S. Jun, S.
Kobayashi, and R.E.J. Mitchel, Low Doses Of Ionising
Radiation Incurred At Low Dose Rates. Journal of the Australasian Radiation Protection
Society, 16, 32-47, (1999).
13. R. E. J.
Mitchel and D. R Boreham, Radiation Protection In The World Of Modern Radiobiology:
Time For A New Approach, Proceedings
of 10th International Congress of the International Radiation Protection Association,
Hiroshima, Japan, Plenary Session 1-2 p. 140, May 2000.
|
|
|